Tessera Therapeutics is planning to lay off 90 employees, the Flagship-founded biotech has warned. | Tessera Therapeutics is ...

The American Society for Reproductive Medicine published a report that concludes preimplantation genetic testing for ...

As of Wednesday, January 07, Design Therapeutics, Inc.’s DSGN share price has surged by 8.50%, which has investors questioning if this is right time to sell.

Vojislav Gligorovski is one of only six recipients of the global International Birnstiel Award for Doctoral Research in ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...

Polygenic background bidirectionally modifies the penetrance of pathogenic variants in hypertrophic (HCM) and dilated (DCM) ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

An ongoing study spotlights the link between calcium deposits in the breast arteries and life-threatening heart risks.

Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is ...

Young adults may face higher risks of cardiovascular disease due to factors like obesity or inactivity. Here, three younger ...

Professional cardiology societies have issued an updated guideline for the management of adult patients with congenital heart ...